barbiturates - CISMeF

Preferred Label : barbiturates;

MeSH definition : A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are GABA MODULATORS used as HYPNOTICS AND SEDATIVES, as ANESTHETICS, or as ANTICONVULSANTS.;

Wikipedia automatic translation : Barbiturate;

MeSH annotation : GEN or unspecified; prefer specifics; general or unspecified; prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Barbiturate;

Is substance : O;

medicament (CISMeF) : O;

Details

Origin ID

D001463;

UMLS CUI

C0004745;

ATC code(s)
- barbiturates and derivatives [ATC Code]
ATC code(s)
- barbiturates and derivatives [ATC Code]
- barbiturates in combination with other drugs [ATC Code]
- barbiturates in combination with other drugs [ATC Code]
- barbiturates, combinations [ATC Code]
- barbiturates, plain [ATC Code]
- barbiturates, plain [ATC Code]
- combinations of barbiturates [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Barbiturate [LOINC component]
- Barbiturate Drug Class Measurement [NCIt concept]
- Barbiturates [HPMULTI term]
- Barbiturates panel [LOINC component]
- Barbiturates positive [LOINC component]
- Barbiturates present [LOINC component]
- Barbiturates tested for [LOINC component]
- Barbiturates.other [LOINC component]
- Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified [ICD-10 category (who)]
- Poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified, undetermined intent [ICD-10 category (who)]
- barbiturates [EMDN type]
- barbiturates [medical devices type]
Currated CISMeF NLP mapping
- Barbiturate [NCIt concept]
- Barbiturate (substance) [SNOMED CT concept]
- Barbiturates [LOINC component]
- Barbiturates [MedDRA Preferred Term]
- Product containing barbiturate (product) [SNOMED CT concept]
- barbiturate, nos [SNOMED Notion]
- barbiturates [IUPAC Term]
False automatic mappings
- Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified [ICD-10 category (who)]
- Barbiturates [ICD-10 Sub-category (who)]
- Poisoning by, adverse effect of and underdosing of barbiturates [ICD-10 Sub-category]
- barbiturate intoxication [Disease (Nov.)]
Indexing information
- barbiturate receptor [MeSH Supplementary Concept]
Record concept(s)
- barbiturates [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1',2'-epoxyvinylbital [MeSH Supplementary Concept]
- 1,3-dibutyl-5-(diaminomethylene)pyrimidine-2,4,6-trione [MeSH Supplementary Concept]
- 1,3-dicyclohexyl-5,5-diallylbarbituric acid [MeSH Supplementary Concept]
- 1,3-dimethoxymethyl-5,5-diphenylbarbituric acid [MeSH Supplementary Concept]
- 1,3-dimethyl-5-(4,4'-bis(dimethylaminophenyl)methylene)-2,4,6-(1H,3H)-pyrimidine-trione [MeSH Supplementary Concept]
- 1,3-dimethyl-5-(4-dimethylaminophenyl)-methylene-2,4,6(1H, 3H)-pyrimidinetrione [MeSH Supplementary Concept]
- 1,3-dimethylbarbital [MeSH Supplementary Concept]
- 1,3-dimethylbarbituric acid [MeSH Supplementary Concept]
- 1,3-dimethylbutylethyl barbituric acid [MeSH Supplementary Concept]
- 1,5,5-triallylbarbituric acid [MeSH Supplementary Concept]
- 1,5-di(but-2-enyl)-5-ethylbarbituric acid [MeSH Supplementary Concept]
- 1,5-dimethylbarbituric acid [MeSH Supplementary Concept]
- 1-(3-chlorophenethyl)-3-cyclopentylpyrimidine-2,4,6-(1H,3H,5H)-trione [MeSH Supplementary Concept]
- 1-4-dimethylaminophenyl-5-allyl-5-(beta-hydroxypropyl)barbituric acid [MeSH Supplementary Concept]
- 1-methyl barbituric acid [MeSH Supplementary Concept]
- 1-n-butyl-5-(2,4-dinitro-phenyl)barbituric acid [MeSH Supplementary Concept]
- 1-n-butyl-5-(4-((1,3-dioxo-1H-inden-(3 H)-ylidene)methyl)phenyl)barbituric acid [MeSH Supplementary Concept]
- 11-fluoro-2,4,8-trimethyl-2,4,4a,6-tetrahydro-1H,1'H-spiro(isoxazolo(4,5-g)(1,4)oxazino(4,3-a)quinoline-5,5'-pyrimidine)-2',4',6'(3'H)-trione [MeSH Supplementary Concept]
- 11-fluoro-2,4-dimethyl-8-(4-methyl-2-oxooxazolidin-3-yl)-2,4,4a,6-tetrahydro-1H,1'H-spiro(isoxazolo(4,5-g)(1,4)oxazino(4,3-a)quinoline-5,5'-pyrimidine)-2',4',6'(3'H)-trione [MeSH Supplementary Concept]
- 2,2'-pyridil into 5,5'-(2-pyrilidine)bisbarbituric acid [MeSH Supplementary Concept]
- 2-hydroxylamino-5-ethyl-5-propylbarbituric acid [MeSH Supplementary Concept]
- 3'-ketobutobarbitone [MeSH Supplementary Concept]
- 4'-hydroxybutobarbitone [MeSH Supplementary Concept]
- 5,5-dimethylbarbituric acid [MeSH Supplementary Concept]
- 5-(((9,10-dioxo-9,10-dihydroanthracen-1-yl)amino)methylidene)-1,3-diazinane-2,4,6-trione [MeSH Supplementary Concept]
- 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)trione [MeSH Supplementary Concept]
- 5-(1,3-dimethylbutyl)-5-barbituric acid [MeSH Supplementary Concept]
- 5-(2-cyclohexylidene-ethyl)-5-ethylbarbiturate [MeSH Supplementary Concept]
- 5-(3-benzyloxy)benzyl-1-((2-hydroxyethoxy)methyl)barbituric acid [MeSH Supplementary Concept]
- 5-(4-(1-(4-(difluoromethoxy)benzoyl)piperidin-4-yloxy)benzylidene)pyrimidine-2,4,6(1H,3H,5H)-trione [MeSH Supplementary Concept]
- 5-(4-(2-hydroxyethyl)piperazin-1-yl)-5-(4-(4-iodophenoxy)phenyl)pyrimidine-2,4,6-trione [MeSH Supplementary Concept]
- 5-(4-oxo-delta(2)-cyclohexenyl)5-allylbarbituric acid [MeSH Supplementary Concept]
- 5-(6-chloro-2,4-dioxo-1,3,4,10-tetrahydro-2H-9-oxa-1,3-diazaanthracen-10-yl)pyrimidine-2,4,6-trione [MeSH Supplementary Concept]
- 5-(hydroxyimino)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione [MeSH Supplementary Concept]
- 5-allyl-5-(beta-hydroxypropyl)-N-phenylbarbituric acid [MeSH Supplementary Concept]
- 5-allyl-5-isopropyl-1-methylbarbituric acid [MeSH Supplementary Concept]
- 5-allyl-beta-oxypropylmalonylurea [MeSH Supplementary Concept]
- 5-aminomethylene-1,3-dibutylbarbituric acid [MeSH Supplementary Concept]
- 5-cyclohexyl-5-ethylbarbituric acid [MeSH Supplementary Concept]
- 5-ethyl-1-phenyl-5-(3,4,5,6-tetrafluorophthalimido)barbituric acid [MeSH Supplementary Concept]
- 5-ethyl-5-(1,3-dimethyl-1-butenyl)barbituric acid [MeSH Supplementary Concept]
- 5-ethyl-5-(1,3-dimethylbutyl)-5-barbituric acid [MeSH Supplementary Concept]
- 5-ethyl-5-(3'-methylbut-2'-enyl)barbituric acid [MeSH Supplementary Concept]
- 5-ethyl-5-(4-fluorobenzoylpropyl)barbituric acid [MeSH Supplementary Concept]
- 5-ethyl-5-(piperidin-1-yl)barbituric acid [MeSH Supplementary Concept]
- 5-ethyl-5-isobutylbarbituric acid [MeSH Supplementary Concept]
- 5-ethyl-5-propyl-1-N-methylbarbituric acid [MeSH Supplementary Concept]
- 5-isopropyl-5-(beta-hydroxypropyl)barbituric acid [MeSH Supplementary Concept]
- 5-nitrobarbituric acid [MeSH Supplementary Concept]
- 6-hydroxyuridine 5'-monophosphate [MeSH Supplementary Concept]
- Dolo-Adamon [MeSH Supplementary Concept]
- GSK1278863 [MeSH Supplementary Concept]
- IMET 176-68 [MeSH Supplementary Concept]
- N(1),N(3)-diethyl-5-(5'-(N(1''),N(3'')-diethyl-2,4,6-trioxo-1,2,3,4,5,6-hexahydropyrimidin-5''-ylidene)-penta-1'3'-diene-1'-yl)barbituric acid [MeSH Supplementary Concept]
- N-(4-(methanesulfonylpiperazin-1-yl)-2,4,6-trioxopyrimidin-4-ylmethyl)-4-((2-methylquinolin-4-yl)methoxy)benzamide [MeSH Supplementary Concept]
- N-hydroxyaprobarbitone [MeSH Supplementary Concept]
- N-methylcyclobarbital [MeSH Supplementary Concept]
- N-n-butylbarbital [MeSH Supplementary Concept]
- PyrzA compound [MeSH Supplementary Concept]
- R-mTFD-MPAB [MeSH Supplementary Concept]
- acetaminophen, butalbital, caffeine drug combination [MeSH Supplementary Concept]
- ajmaline phenylbarbiturate [MeSH Supplementary Concept]
- allobarbital [MeSH Supplementary Concept]
- alloxantin [MeSH Supplementary Concept]
- allylpropymal [MeSH Supplementary Concept]
- aspirin, butalbital and caffeine drug combination [MeSH Supplementary Concept]
- barbituric acid [MeSH Supplementary Concept]
- barverin [MeSH Supplementary Concept]
- benzobarbital [MeSH Supplementary Concept]
- beuthanasia special [MeSH Supplementary Concept]
- bis(1,3-dibutylbarbiturate)trimethine oxonol [MeSH Supplementary Concept]
- bis(1,3-dibutylbarbituric acid)pentamethine oxonol [MeSH Supplementary Concept]
- brallobarbital [MeSH Supplementary Concept]
- brallobarbital, hydroxyzine, secobarbital drug combination [MeSH Supplementary Concept]
- bucolome [MeSH Supplementary Concept]
- bucolome N-glucuronide [MeSH Supplementary Concept]
- butalbital [MeSH Supplementary Concept]
- butobarbital [MeSH Supplementary Concept]
- butylvinal [MeSH Supplementary Concept]
- complexe 1656 [MeSH Supplementary Concept]
- crotarbital [MeSH Supplementary Concept]
- cyclobarbital [MeSH Supplementary Concept]
- dialuric acid [MeSH Supplementary Concept]
- difebarbamate [MeSH Supplementary Concept]
- eunalgit [MeSH Supplementary Concept]
- febarbamate [MeSH Supplementary Concept]
- fortalidon [MeSH Supplementary Concept]
- halonal [MeSH Supplementary Concept]
- heptabarbital [MeSH Supplementary Concept]
- isouramil [MeSH Supplementary Concept]
- itridal [MeSH Supplementary Concept]
- merbaphen [MeSH Supplementary Concept]
- metharbital [MeSH Supplementary Concept]
- nealbarbital [MeSH Supplementary Concept]
- neo-secatropin [MeSH Supplementary Concept]
- optalidon [MeSH Supplementary Concept]
- oxonol dyes (barbiturate) [MeSH Supplementary Concept]
- pabialgin P [MeSH Supplementary Concept]
- pronarcon [MeSH Supplementary Concept]
- propallylonal [MeSH Supplementary Concept]
- proxibarbal [MeSH Supplementary Concept]
- pyridium plus [MeSH Supplementary Concept]
- reladorm [MeSH Supplementary Concept]
- secbutabarbital [MeSH Supplementary Concept]
- spasmo-eunalgit [MeSH Supplementary Concept]
- spasmoplus [MeSH Supplementary Concept]
- talbutal [MeSH Supplementary Concept]
- thiazolidinonyl 2-oxobarbituric acid [MeSH Supplementary Concept]
- thiazolidinonyl 2-thiobarbituric acid [MeSH Supplementary Concept]
- violuric acid [MeSH Supplementary Concept]
- zoliflodacin [MeSH Supplementary Concept]
See also
- anesthetics, intravenous [MeSH Descriptor]
- anticonvulsants [MeSH Descriptor]
- hypnotics and sedatives [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Barbiturate [LOINC component]
- Barbiturate [NCIt concept]
- Barbiturate (substance) [SNOMED CT concept]
- Barbiturates [LOINC component]
- Product containing barbiturate (product) [SNOMED CT concept]
- barbiturate, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients